{A figure is presented}Single-Gene Autosomal Recessive Disorders and Prader-Willi Syndrome: An Update for Food and Nutrition Professionals{A figure is presented}

Journal of the American Dietetic Association

Volumn 107, Issue 3, 2007, Pages 466-478

  Isaacs, Janet Sugarman ^a   Zand, Dina J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENETIC SCREENING; GENETICS; HUMAN; INBORN ERROR OF METABOLISM; MASS SPECTROMETRY; METHODOLOGY; NEWBORN; NEWBORN SCREENING; NUTRITIONAL DISORDER; PRADER WILLI SYNDROME; REVIEW;

GENETIC SCREENING; HUMANS; INFANT, NEWBORN; MASS SPECTROMETRY; METABOLISM, INBORN ERRORS; NEONATAL SCREENING; NUTRITION DISORDERS; PRADER-WILLI SYNDROME;

EID: 33847159594     PISSN: 00028223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jada.2006.12.006     Document Type: Article

References (56)

1. Human Genome Project information. Available at: http://www.ornl.gov/sci/techresources/Human_Genome/home.shtml. Accessed October 26, 2005.
2. Millington D.S. Newborn screening for metabolic disease. Am Sci 90 (2002) 40-47
3. Saudubray J.-M., and Charpentier C. Clinical phenotypes: Diagnosis/algorithms. In: Scriver C., Beaudet A., Sly W., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease (2001), McGraw-Hill, New York, NY 1327-1403
4. Sims E.J., McCormick J., Mehta G., Mehta A., and Steering Committee of the UK Cystic Fibrosis Database. Neonatal screening for cystic fibrosis is beneficial even in the context of modern treatment. J Pediatr 147 3 suppl (2005) S42-S46
5. ARUP Laboratories. Available at: http://www.aruplab.com/TestDirectory/testdirectory.jsp. Accessed January 13, 2007.
6. Devlin L., and Morrison P.J. Accuracy of the clinical diagnosis of Down syndrome. Ulster Med J 73 (2004) 4-12
7. Cataldo C.B., Debruyne L.K., and Whitney E.N. Nutrition and Diet Therapy. 5th ed (1998), Wadsworth Publishing Co, Stamford, CT
8. Trahms C.M., and Pipes P.L. Nutrition in Infancy and Childhood. 6th ed (1997), McGraw-Hill, New York, NY
9. Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (2005), The National Academies Press, Washington, DC 589-768
10. Scriver C.R., and Kaufman S. Hyperphenylalaninemia: Phenylalanine hydroxylase deficiency. In: Scriver C., Beaudet A., Sly W., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease (2001), McGraw-Hill, New York, NY 1667-1724
11. Chuang D.T., and Shih V.E. Maple syrup urine disease (branched-chain ketoaciduria). In: Scriver C., Beaudet A., Sly W., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease (2001), McGraw-Hill, New York, NY 1971-2006
12. Fenton W.A., Gravel R.A., and Rosenblatt D.S. Disorders of propionate and methylmalonate metabolism. In: Scriver C., Beaudet A., Sly W., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease (2001), McGraw-Hill, New York, NY 2165-2194
13. de Baulny H.O., Benoist J.F., Rigal O., Touati G., Rabier D., and Saudubray J.M. Methylmalonic and propionic acidaemias: management and outcome. J Inherit Metab Dis 28 (2005) 415-423
14. Organic Acidemia Association homepage. Available at: http://www.oaanews.org. Accessed October 28, 2005.
15. Joshi S.N., and Venugopalan P. Experience with NTBC therapy in hereditary tyrosinaemia type I: An alternative to liver transplantation. Ann Trop Paediatr 24 (2004) 259-265
16. Zschocke J., and Hoffmann G.F. Vademecum Metabolicum. 2nd ed (2004), Milupa, Friedrichsdorf, Germany 61-64
17. New developments in urea cycle disorders. Proceedings of a satellite workshop at the IX International Congress on Inborn Errors of Metabolism. August 31-September 1, 2003. Sydney, Australia. Mol Genet Metab. 2004;81(suppl 1):S3-S91.
18. American College of Medical Genetics. Newborn screening: Toward a uniform screening panel and system. 2005 Final Report (2005). http://mchb.hrsa.gov/screening Available at: http://mchb.hrsa.gov/screening. Accessed October 24
19. Ievers-Landis C.E., Hoff A.L., Brez C., Cancilliere M.K., McConnell J., and Kerr D. Situational analysis of dietary challenges of the treatment regimen for children and adolescents with phenylketonuria and their primary caregivers. J Dev Behav Pediatr 26 (2005) 186-193
20. Oey N.A., den Boer M.E., Wijburg F.A., Vekemans M., Auge J., Steiner C., Wanders R.J., Waterham H.R., Ruiter J.P., and Attie-Bitach T. Long-chain fatty acid oxidation during early human development. Pediatr Res 57 (2005) 755-759
21. The Fatty Oxidation Disorders Family Support Group homepage. Available at: http://www.fodsupport.org/. Accessed October 28, 2005.
22. Roe C.R., and Ding J. Mitochrondrial fatty acid oxidation disorders. In: Scriver C., Beaudet A., Sly W., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease (2001), McGraw-Hill, New York, NY 2297-2326
23. Nennstiel-Ratzel U., Arenz S., Maier E.M., Knerr I., Baumkotter J., Roschinger W., Liebl B., Hadorn H.B., Roscher A.A., and von Kries R. Reduced incidence of severe metabolic crisis or death in children with medium-chain acyl-CoA dehydrogenase deficiency homozygous for c.985A>G identified by neonatal screening. Molec Gen Metab 85 (2005) 157-159
24. X-linked adrenoleukodystrophy. Available at: http://www.geneclinics.org/profiles/x-ald. Accessed October 28, 2005.
25. Merkens L.S., Connor W.E., Linck L.M., Lin D.S., Flavell D.P., and Steiner R.D. Effects of dietary cholesterol on plasma lipoproteins in Smith-Lemli-Opitz syndrome. Pediatr Res 56 (2004) 726-732
26. Holton J.B., Walter J.H., and Tyfield L.A. Galactosemia. In: Scriver C., Beaudet A., Sly W., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease (2001), McGraw-Hill, New York, NY 1553-1588
27. Steinmann B., Gitzelmann R., and Van den Berghe G. Disorders of fructose metabolism. In: Scriver C., Beaudet A., Sly W., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease (2001), McGraw-Hill, New York, NY 1489-1520
28. Chen Y.-T. Glycogen storage diseases. In: Scriver C., Beaudet A., Sly W., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease (2001), McGraw-Hill, New York, NY 1521-1552
29. Bodamer O.A., Feillet F., Lane R.E., Lee P.J., Dixon M.A., Halliday D., and Leonard J.V. Utilization of cornstarch in glycogen storage disease type 1A. Eur J Gastroenterol Hepatol 14 (2002) 1251-1256
30. Jawan B., Tseng C.C., Chen Y.S., Wang C.C., Cheng Y.F., Huang T.L., Eng H.L., Chiu K.W., Wang S.H., Lin C.C., Lin T.S., Liu Y.W., and Chen C.L. Is there any difference in anesthetic management of biliary atresia and glycogen storage disease patients undergoing liver transplantation?. J Surg Res 126 (2005) 82-85
31. Klepper J., Leiendecker B., Bredahl R., Athanassopoulos S., Heinen F., Gertse Florcken A., Metz A., and Voit T. Introduction of a ketogenic diet in young infants. J Inherit Metab Dis 25 (2002) 449-460
32. Chinney P.F., and Turnbull D.M. Epidemiology and treatment of mitochondrial disorders. Am J Med Genet 106 (2001) 94-101
33. Gardner R.J.M., and Sutherland G.R. Chromosome Abnormalities and Genetic Counseling. 3rd ed (2004), Oxford University Press, Oxford, UK 3311-3335
34. Millington D., and Koeberl D. Metabolic screening in the newborn. Growth Genet Horm 19 (2003) 32-38
35. Heidt K., Schwahn B., Marquardt I., Grotzke M., and Wendel U. Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification. Mol Genet Metab 84 (2005) 313-316
36. Lai H.J., Cheng Y., and Farrell P.M. The survival advantage of patients with cystic fibrosis diagnosed through neonatal screening: Evidence from the United States cystic fibrosis foundation registry data. J Pediatr 147 suppl 3 (2005) S57-S63
37. Marsden D. Expanded newborn screening by tandem mass spectrometry: The Massachusetts and New England experience. Southeast Asian J Trop Med Public Health 34 suppl 3 (2003) 111-114
38. Waisbren S.E., Albers S., Amato S., Ampola M., Brewster T.G., Demmer L., Eaton R.B., Greenstein R., Korson M., Larson C., Marsden D., Msall M., Naylor E.W., Pueschel S., Seashore M., Shih V.E., and Levy H.L. Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress. JAMA 290 (2003) 2564-2572
39. Ensenauer R., Vockley J., Willard J.M., Huey J.C., Sass J.O., Edland S.D., Burton B.K., Berry S.A., Santer R., Grunert S., Koch H.G., Marquardt I., Rinaldo P., Hahn S., and Matern D. A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening. Am J Hum Genet 75 (2004) 1136-1142
40. Techakittiroj C., Cunningham A., Hooper P.F., Andersson H.C., and Thoene J. High protein diet mimics hypertyrosinemia in newborn infants. J Pediatr 146 (2005) 281-282
41. Cystic Fibrosis Foundation Consensus Conference. Concepts in Cystic Fibrosis Care: Pediatric Nutrition for Patients with Cystic Fibrosis (2002), Cystic Fibrosis Foundation, Bethesda, MD
42. Borowitz D., Baker R.D., and Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 35 (2002) 246-259
43. Wilfond B.S., and Gollust S.E. Policy issues for expanding newborn screening programs: The cystic fibrosis newborn screening experience in the United States. J Pediatr 146 (2005) 668-674
44. Pediatrix screening (2005). http://www.pediatrixscreening.com Available at: http://www.pediatrixscreening.com. Accessed October 28
45. Siret D., Bretaudeau G., Branger B., Dabadie A., Dagorne M., David V., de Braekeleer M., Moisan-Petit V., Picherot G., Rault G., Storni V., and Roussey M. Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: A 10-year retrospective study in a French region (Brittany). Pediatr Pulmonol 35 (2003) 342-349
46. Rock M.J., Hoffman G., Laessig R.H., Kopish G.J., Litsheim T.J., and Farrell P.M. Newborn screening for cystic fibrosis in Wisconsin: Nine-year experience with routine trypsinogen/DNA testing. J Pediatr 147 suppl 3 (2005) S73-S77
47. DelParigi A., Tschop M., Heiman M.L., Salbe A.D., Vozarova B., Sell S.M., Bunt J.C., and Tataranni P.A. High circulating ghrelin: A potential calciumuse for hyperphagia and obesity in Prader-Willi syndrome. J Clin Endocrinol Metab 87 (2002) 5461-5464
48. Paro-Panjan D., and Neubauer D. Congenital hypotonia: Is there an algorithm?. J Child Neurol 19 (2004) 439-442
49. Cassidy S.B. Prader-Willi syndrome. In: Cassidy S.B., and Allanson J.E. (Eds). Management of Genetic Syndromes. 2nd ed (2005), John Wiley and Sons, New York, NY 429-448
50. Eiholzer U., and Whitman B.Y. A comprehensive team approach to the management of patients with Prader-Willi syndrome. J Pediatr Endocrinol Metab 17 (2004) 1153-1175
51. Trifiro G., Livieri C., Bosio L., Gargantini L., Corrias A., Pozzan G., Crino A., and Genetic Obesity Study Group of the Italian Society of Paediatric Endocrinology and Diabetology. Neonatal hypotonia: Don't forget the Prader-Willi syndrome. Acta Paediatr 92 (2003) 1085-1089
52. Eiholzer U. Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS. Horm Res 63 (2005) 33-39
53. Bizzarri C., Rigamonti A.E., Giannone G., Berardinelli R., Cella S.G., Cappa M., and Muller E.E. Maintenance of a normal meal-induced decrease in plasma ghrelin levels in children with Prader-Willi syndrome. Horm Metab Res 36 (2004) 164-169
54. Morioka D., Takada Y., Kasahara M., Ito T., Uryuhara K., Ogawa K., Egawa H., and Tanaka K. Living donor liver transplantation for noncirrhotic inheritable metabolic liver diseases: Impact of the use of heterozygous donors. Transplantation 80 (2005) 623-628
55. Schonberger S., Schweiger B., Schwahn B., Schwarz M., and Wendel U. Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. Mol Genet Metab 82 (2004) 69-75
56. Huner G., Baykal T., Demir F., and Demirkol M. Breastfeeding experience in inborn errors of metabolism other than phenylketonuria. J Inher Metab Dis 28 (2005) 457-465